AVITA MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.73 AUD | +3.80% |
|
+1.49% | -36.36% |
| 17/04 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
| 11/04 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Chart calendar AVITA Medical, Inc.
2d450f5cc5d4324a8c45a.FIC3DsK6vLrkntcSUf9aIwPNB5rIP28pPpdtcrT-jh0.d9HiRonNj_m9yOVVIp0QdXupTuv9Ul5LSM4bI9-UzXZ969B4jsDG_KmsuA~cac2468b11d062c586776ed371143c9a
Upcoming events on AVITA Medical, Inc.
Past events on AVITA Medical, Inc.
| 05/03/2024 08:20 pm | TD Cowen Health Care Conference |
| 28/02/2024 03:30 am | Business Update Call |
| 23/02/2024 03:00 am | Q4 2023 Earnings Call |
| 23/02/2024 02:45 am | Q4 2023 Earnings Release |
| 12/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 06/12/2023 03:30 am | Business Update Call |
| 28/11/2023 11:30 pm | Piper Sandler Healthcare Conference |
| 10/11/2023 03:00 am | Q3 2023 Earnings Call |
| 10/11/2023 02:31 am | Q3 2023 Earnings Release |
| 26/09/2023 08:35 pm | Cantor Global Healthcare Conference |
| 14/09/2023 | Lake Street Capital Markets Big7 Conference |
| 13/09/2023 11:45 pm | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 16/08/2023 04:30 am | Investor Meeting |
| 11/08/2023 02:00 am | Q2 2023 Earnings Call |
| 11/08/2023 01:31 am | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 17,0 16,7 2.17% | 19,7 27,3 -27.77% | 40,3 33,8 19.18% | 50,6 49,8 1.65% | 76,6 75,4 1.72% | 115 |
|
EBITDA Million AUD | Released Forecast Spread | -32,0 -30,1 -6.39% | -35,6 -34,4 -3.31% | -27,8 -34,9 20.38% | -38,3 -43,9 12.67% | -64,2 -61,0 -5.34% | -56,7 |
|
EBIT Million AUD | Released Forecast Spread | -34,7 -30,2 -15.05% | -59,0 -35,7 -65.17% | -36,6 -38,8 5.68% | -40,5 -43,8 7.62% | -65,2 -61,8 -5.47% | -57,3 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -34,8 -31,3 -10.96% | -58,1 -36,5 -59.27% | -36,6 -39,5 7.43% | -39,2 -41,8 6.33% | -54,0 -59,1 8.64% | -54,8 |
|
Net income Million AUD | Released Forecast Spread | -34,6 -30,0 -15.44% | -58,1 -36,5 -59.16% | -36,7 -40,0 8.3% | -39,2 -43,7 10.15% | -54,1 -59,2 8.63% | -56,9 |
|
EPS AUD | Released Forecast Spread | -0,03 -0,02 -36.5% | -2,86 -0,02 -13313.74% | -1,61 -1,77 8.74% | -1,57 -1,69 6.95% | -2,14 -2,29 6.42% | -2,10 |
| Announcement Date | 29/08/19 | 27/08/20 | 26/08/21 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 10,2 9,75 4.64% | 13,5 16,0 -15.31% | 10,7 18,0 -40.3% | 14,2 10,8 31.49% | 11,0 9,22 19.02% | 11,7 10,5 11.51% | 13,8 11,0 25.58% | 13,9 13,0 7.33% | 15,8 15,4 2.56% | 17,9 16,8 6.69% | 21,2 21,0 1.27% | 21,7 21,1 2.88% | 17,1 | 25,4 | 32,8 | 38,8 | 31,4 |
|
EBITDA Million AUD | Released Forecast Spread | -17,5 -15,1 -16.06% | -15,7 -15,4 -1.95% | -38,4 -13,5 -184.81% | -4,30 -5,23 17.86% | -13,5 -10,6 -27.74% | -8,59 -13,2 34.74% | -8,27 -11,3 26.88% | -7,64 -10,3 25.94% | -13,5 -11,5 -17.46% | -16,8 -13,2 -27.14% | -14,2 -18,6 23.27% | -18,5 -16,5 -12.08% | -20,6 | -16,7 | -11,7 | -10,8 | -8,13 |
|
EBIT Million AUD | Released Forecast Spread | -19,2 -14,6 -31.37% | -21,0 -16,2 -29.47% | -39,3 -15,7 -150.42% | -6,49 -8,88 26.97% | -13,8 -12,2 -13.56% | -8,94 -13,1 31.87% | -8,74 -12,0 27.39% | -8,69 -10,3 15.61% | -14,8 -9,35 -58.3% | -17,0 -12,1 -40.54% | -14,5 -17,5 17.25% | -18,8 -15,0 -25.04% | -19,4 | -16,0 | -12,4 | -9,63 | -8,43 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -19,2 -16,9 -13.52% | -38,6 -17,9 -116.09% | -6,50 -8,88 26.86% | -13,8 -12,1 -13.97% | -8,79 -13,1 32.96% | -8,49 -12,0 29.46% | -7,84 -10,3 23.88% | -13,7 -9,58 -43.33% | -15,8 -12,3 -28.45% | -13,6 -17,3 21.58% | -10,8 -15,2 29.3% | -19,2 | -15,8 | -12,1 | -9,39 | -8,05 | |
|
Net income Million AUD | Released Forecast Spread | -20,4 -15,5 -31.24% | -31,3 -15,6 -100.68% | -38,6 -20,7 -87.09% | -6,51 -9,16 28.96% | -13,8 -12,5 -9.91% | -8,80 -13,5 34.79% | -8,50 -12,4 31.23% | -7,87 -10,6 25.68% | -13,8 -9,88 -39.36% | -15,8 -12,6 -25.76% | -13,6 -17,6 22.71% | -10,8 -15,5 30.47% | -19,2 | -15,8 | -12,1 | -9,40 | -8,06 |
|
EPS AUD | Released Forecast Spread | -0,01 -0,01 -14% | -1,81 -0,01 -36113.6% | -0,26 -0,38 30.14% | -0,55 -0,53 -3.8% | -0,35 -0,58 39.6% | -0,33 -0,51 34.89% | -0,31 -0,41 24.29% | -0,55 -0,35 -56.69% | -0,63 -0,45 -38.87% | -0,53 -0,69 23.6% | -0,43 -0,57 24.65% | -0,73 | -0,58 | -0,45 | -0,32 | -0,31 | |
| Announcement Date | 29/08/19 | 31/01/20 | 27/08/20 | 26/08/21 | 12/05/22 | 11/08/22 | 10/11/22 | 23/02/23 | 11/05/23 | 10/08/23 | 09/11/23 | 22/02/24 | - | - | - | - | - |
| Today 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| Today 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| Today 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | REVOLUTION MEDICINES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | SYNDAX PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for AVITA Medical, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RCEL Stock
- AVH Stock
- Calendar AVITA Medical, Inc.
